Kris Licht

Kris Licht serves as CEO of Reckitt Benckiser, a global consumer health, hygiene, and nutrition company headquartered in the UK. Reckitt's portfolio includes some of the world's most recognizable household brands: Lysol and Dettol (disinfectants), Mucinex and Nurofen (OTC health), Enfamil and Nutramigen (infant nutrition), Durex (sexual wellness), Finish (dishwashing), Vanish (laundry), and Air Wick (air care). Reckitt is undergoing a significant strategic transformation. The company is restructuring around its strongest brands in health and hygiene — categories with higher growth, better margins, and stronger competitive moats — while evaluating options for the nutrition business (Mead Johnson, acquired for $17 billion in 2017). The nutrition unit has been challenged by the U.S. infant formula market disruption and litigation related to necrotizing enterocolitis (NEC) in premature infants. The company experienced extraordinary demand during COVID-19 for its disinfectant brands (Lysol, Dettol), followed by a normalization period as pandemic-era cleaning habits moderated. Reckitt's challenge is demonstrating sustainable organic growth in its core categories without pandemic tailwinds. Key stock drivers include organic revenue growth, gross margin recovery, nutrition business disposition or resolution, NEC litigation outcomes, emerging market growth, and the pace of portfolio simplification.